Document Detail

Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.).
MedLine Citation:
PMID:  19903379     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: Myocardial fibrosis and oxidative stress accompany a number of cardiac disorders such as hypertrophic cardiomyopathy, hypertensive heart disease and cardiac failure. Stem bark of Terminalia arjuna has been advocated for cardiac ailments. The present study evaluated the effects of T. arjuna bark extract on myocardial fibrosis and oxidative stress induced by chronic beta-adrenoceptor stimulation.
METHODS: Aqueous extract of T. arjuna bark was evaluated at 63, 125 and 250 mg/kg given orally for antifibrotic and antioxidant effects in rats given the selective beta-adrenoceptor agonist isoprenaline (5 mg/kg s.c.) for 28 days. Captopril (50 mg/kg per day, given orally), an inhibitor of angiotensin-converting enzyme used as a standard cardioprotective drug, was used as a positive control.
KEY FINDINGS: Isoprenaline caused fibrosis, increased oxidative stress and cardiac hypertrophy (increased heart weight : body weight ratio and cardiomyocyte diameter). The T. arjuna bark extract and captopril significantly prevented the isoprenaline-induced increase in oxidative stress and decline in endogenous antioxidant level. Both also prevented fibrosis but not the increase in heart weight : body weight ratio.
CONCLUSIONS: T. arjuna protects against myocardial changes induced by chronic beta-adrenoceptor stimulation.
Santosh Kumar; Rajesh Enjamoori; Amardeep Jaiswal; Ruma Ray; Sandeep Seth; Subir Kumar Maulik
Related Documents :
16153919 - Gene transfection of hepatocyte growth factor attenuates the progression of cardiac rem...
15364619 - Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarct...
1918369 - Alteration of collagen phenotypes in ischemic cardiomyopathy.
20579749 - Oestradiol supplement minimises coronary occlusion-induced myocardial infarction and ve...
18088389 - Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure.
6785949 - Effects of antiplatelet and calcium antagonist drugs on infarct size in rats.
302779 - Echocardiographic and roentgenographic determination of left ventricular size after cor...
1752009 - Clinical application of cardiac risk indices: how to avoid misleading numbers.
9577279 - Range of echocardiographic findings in term neonates with high oxygen requirements.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pharmacy and pharmacology     Volume:  61     ISSN:  2042-7158     ISO Abbreviation:  J. Pharm. Pharmacol.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-11     Completed Date:  2010-03-16     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  0376363     Medline TA:  J Pharm Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1529-36     Citation Subset:  IM    
Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Agonists
Antioxidants / pharmacology*
Captopril / pharmacology
Cardiomegaly / drug therapy
Fibrosis / chemically induced,  prevention & control
Heart / drug effects
Isoproterenol / pharmacology
Myocardium / pathology*
Organ Size
Oxidative Stress / drug effects*
Peptidyl-Dipeptidase A
Plant Bark
Plant Extracts / pharmacology*
Plant Stems
Rats, Wistar
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Antioxidants; 0/Plant Extracts; 62571-86-2/Captopril; 7683-59-2/Isoproterenol; EC A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice.
Next Document:  Nootropic activity of lipid-based extract of Bacopa monniera Linn. compared with traditional prepara...